Bevacizumab is associated with delayed anastomotic leak after low anterior resection with preoperative radiotherapy for rectal cancer: a case report

BACKGROUND: Bevacizumab is an anti-angiogenesis agent used to treat patients with metastatic colorectal cancer and is associated with a variety of complications. We present a patient with rectal cancer who developed a delayed anastomotic leak more than 5 years after undergoing low anterior resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Machida, Erika, Miyakura, Yasuyuki, Takahashi, Jun, Tamaki, Sawako, Ishikawa, Hideki, Hasegawa, Fumi, Kikugawa, Rina, Tsujinaka, Shingo, Lefor, Alan Kawarai, Rikiyama, Toshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357210/
https://www.ncbi.nlm.nih.gov/pubmed/30706233
http://dx.doi.org/10.1186/s40792-019-0573-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357210/
https://www.ncbi.nlm.nih.gov/pubmed/30706233
http://dx.doi.org/10.1186/s40792-019-0573-1

Ejemplares similares